(SMCX) Defiance Daily Target 2X - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Trading--Leveraged Equity

SMCX: Derivatives, Collateral

The Defiance Daily Target 2X Long SMCI ETF (NASDAQ:SMCX) is an actively managed exchange-traded fund designed to deliver twice the daily percentage change of the underlying security, SMCI. It achieves this through the use of swap agreements, which are financial contracts that allow the fund to gain exposure to the performance of the underlying asset without directly holding it. The fund is classified as non-diversified, meaning it may concentrate its investments in a smaller number of securities, which can increase risk but also potentially amplify returns.

From a technical standpoint, SMCX is currently trading at $58.08, below its 20-day simple moving average (SMA) of $67.45 and its 50-day SMA of $52.86. However, it remains well below its 200-day SMA of $106.11, indicating a significant decline over the longer term. The Average True Range (ATR) of 11.90 suggests moderate volatility, with price swings of approximately 20% over a 20-day period. The average daily trading volume of 4,103,544 shares provides sufficient liquidity for most investors.

Fundamentally, SMCX manages assets under management (AUM) of $383.02 million, positioning it as a mid-sized ETF with adequate scale to maintain market impact while still being agile enough to adjust its positions as needed. The funds focus on delivering leveraged returns makes it a tool for sophisticated investors seeking to capitalize on short-term price movements in SMCI.

Over the next three months, based on the current technical and fundamental data, SMCX is expected to experience continued volatility. The gap between the 20-day SMA and the 200-day SMA suggests bearish momentum, with potential downside risks. However, if SMCI experiences a rebound, the funds 2x leverage could amplify gains. The ATR of 11.90 indicates that price fluctuations will likely remain significant, with potential swings of 15-20% in either direction. Investors should monitor the funds performance closely, as leveraged ETFs are designed for short-term trading and may not be suitable for long-term holding.

Additional Sources for SMCX ETF

SMCX ETF Overview

Market Cap in USD 241m
Category Trading--Leveraged Equity
IPO / Inception 2024-08-21

SMCX ETF Ratings

Growth 5y -38.5%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -76.8
Analysts -
Fair Price Momentum 36.94 USD
Fair Price DCF -

SMCX Dividends

No Dividends Paid

SMCX Growth Ratios

Growth Correlation 3m 21.4%
Growth Correlation 12m -63.1%
Growth Correlation 5y -63.1%
CAGR 5y -76.87%
CAGR/Max DD 5y -0.81
Sharpe Ratio 12m -0.92
Alpha -133.57
Beta 8.08
Volatility 262.05%
Current Volume 2613.5k
Average Volume 20d 4662.4k
What is the price of SMCX stocks?
As of March 15, 2025, the stock is trading at USD 51.81 with a total of 2,613,500 shares traded.
Over the past week, the price has changed by +17.62%, over one month by -36.58%, over three months by +7.16% and over the past year by -76.87%.
Is Defiance Daily Target 2X a good stock to buy?
Probably not. Based on ValueRay Analyses, Defiance Daily Target 2X (NASDAQ:SMCX) is currently (March 2025) not a good stock to buy. It has a ValueRay Growth Rating of -38.51 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SMCX as of March 2025 is 36.94. This means that SMCX is currently overvalued and has a potential downside of -28.7%.
Is SMCX a buy, sell or hold?
Defiance Daily Target 2X has no consensus analysts rating.
What are the forecast for SMCX stock price target?
According to ValueRays Forecast Model, SMCX Defiance Daily Target 2X will be worth about 44.3 in March 2026. The stock is currently trading at 51.81. This means that the stock has a potential downside of -14.44%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 44.3 -14.4%